APG Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.49M | Buy |
|
|||||
|
2025
Q1 | $5.93M | Sell |
|
|||||
|
2024
Q4 | $7.93M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $33.1M | Sell |
|
|||||
|
2024
Q1 | $48.2M | Sell |
|
|||||
|
2023
Q4 | $45.6M | Buy |
|
|||||
|
2023
Q3 | $37.8M | Buy |
|
|||||
|
2023
Q2 | $27.2M | Sell |
|
|||||
|
2023
Q1 | $30.4M | Buy |
|
|||||
|
2022
Q4 | $37.2M | Buy |
|
|||||
|
2022
Q3 | $25.4M | Sell |
|
|||||
|
2022
Q2 | $30.2M | Buy |
|
|||||
|
2022
Q1 | $27.1M | Sell |
|
|||||
|
2021
Q4 | $24.2M | Buy |
|
|||||
|
2021
Q3 | $630K | Sell |
|
|||||
|
2021
Q2 | $748K | Sell |
|
|||||
|
2021
Q1 | $9.8M | Sell |
|
|||||
|
2020
Q4 | $13M | Sell |
|
|||||
|
2020
Q3 | $15.3M | Buy |
|
|||||
|
2020
Q2 | $15.4M | Buy |
|
|||||
|
2020
Q1 | $8.79M | Buy |
|
|||||
|
2019
Q4 | $5.27M | Buy |
|